Suggested blood donor deferral strategy regarding hepatitis B infections in China.
Ling LiRui WangJin GuoLiu HeZhengmin LiuQianqian QinJing ZhangShuo WuLiqin HuangHongwei GeZhong LiuPublished in: Transfusion medicine (Oxford, England) (2024)
These findings suggest that adopting a screening algorithm for deferring HBV reactive blood donors based on HBsAg and NAT testing followed with HBsAg S/CO consideration and HBcAg testing can be both safe and feasible in China.